SOURCE: Equities Global Communications, Inc.

September 18, 2007 20:13 ET

Martin Graham, Director of Markets of the London Stock Exchange, to Speak at the EQUITIES Transatlantic Conference

LONDON--(Marketwire - September 18, 2007) - EQUITIES Magazine proudly announces its Second Annual Transatlantic Conference, to be held at the NASDAQ MarketSite in New York City on Sept. 28, 2007, and at the London Stock Exchange on Oct. 1, 2007.

In London, the keynote speaker will be Martin Graham, director of markets of the London Stock Exchange and the managing director of the Alternative Investment Market. Mr. Graham also serves as a board member of FTSE International, the Indo British Partnership, and EDX (the LSE's equity-derivitives market). The guest speaker in London is Oxford Metrica chairman Dr. Rory Knight, who brings years of experience and insight to the conference. Dr. Knight serves as Dean Emeritus at Oxford University's Templeton College and is a member of the John Templeton Foundation advisory board.

The EQUITIES 2007 Second Annual Transatlantic Conference will include some of the most promising emerging companies in the world. The following is a partial list of London presenters:

--  MidasTrade.com Inc. (PINKSHEETS: MIDS): MidasTrade.com is committed to
    providing foreign investors, traders, and institutions with direct
    electronic access to U.S. securities markets with minimal surcharges and
    commission fees. Through the MidasTrade network, the company has developed
    the Global Direct Access Network, a proprietary software-trading platform
    that allows investors to trade securities, options, and futures in real
    time via its online trading account.
    
--  Osteologix (OTCBB: OLGX): Osteologix is engaged in the acquisition,
    development and commercialization of novel drugs for metabolic and
    musculoskeletal diseases. Its lead product, NB S101, targeting the $10
    billion osteoporosis market, helps the body rebuild bone in a manner more
    similar to its own natural process by rebalancing bone metabolism in a way
    that favors strong bone development.
    
--  Hollis-Eden Pharmaceuticals Inc. (NASDAQ: HEPH): A world leader in the
    development of a proprietary class of adrenal steroid hormones as novel
    pharmaceuticals for human health. The company's clinical drug development
    candidates include HE3286, currently in a Phase I clinical trial for type
    II diabetes and in preparation for potential clinical trials in diseases of
    inflammation, and HE3235, which has been selected for cancer.
    
--  Quinto Mining Corp. (PINKSHEETS: QUTMF): A mineral exploration company
    with two advanced projects located in Quebec, Canada. Its primary property
    is the Peppler Lake iron ore property. Situated within the iron ore
    producing region of Quebec, the Peppler Lake property is located close to
    major infrastructure, rail hydro and road systems. Peppler's current drill
    program is showing signs of significant tonnage. The advanced high grade
    high tonnage Lac Gueret graphite property is also well on its way to a
    production decision.
    
    

To register, RSVP at http://www.equitiesmagazine.com/conferences

email invitedguest@equitiesmagazine.com or call (310) 207-5300

Live and archived Webcasts of the event will be available at www.equitiesmagazine.com.

About EQUITIES Global Communications, Inc.

EQUITIES Magazine

Since 1981, EQUITIES Corporate Conferences have been staples within the industry, pairing the most exciting emerging companies in the world with sophisticated audiences of institutional and private investors.

EQUITIES has provided a voice and an audience to leaders in the global financial community for 56 years, and we remain the definitive investor's tool.

Safe Harbor -- This press release and the EQUITIES conference it announces are not to be construed, under any circumstances, by implication or otherwise, as an offer or an endorsement to sell or a solicitation to buy or trade in any commodities or securities therein named.

We note that each conference presenter paid EQUITIES. Any forward-looking statements made by the presenting companies are in no way endorsed by EQUITIES Global Communications Inc. and EQUITIES Magazine and we cannot guarantee any sort of performance for these stocks.

EQUITIES Global Communications, Inc., EQUITIES Magazine and its employees are not, nor do they claim to be, registered investment advisors or broker/dealers. EQUITIES Conferences contain forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934 relating to companies' future operating results that are subject to certain risks that could cause results to differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements. This publication undertakes no obligation to update these forward-looking statements. EQUITIES Magazine, its owners, employees, their families and associates may have investments in companies featured in this press release and in our conferences and may elect to sell these investments or purchase additional investments in the aforementioned companies at any time. Investors, conference audience members, web cast listeners and EQUITIES Magazine readers should do their own due diligence before investing in any securities mentioned. Investing in securities is speculative and carries a high degree of risk.

Contact Information